Clinical Trials in Kaifeng, Henan
23 recruiting
Showing 1–20 of 21 trials
Recruiting
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
Carcinoma, Non-Small Cell Lung
Hoffmann-La Roche800 enrolled41 locationsNCT06862869
Recruiting
Phase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
ObesityHeart Failure With Preserved Ejection FractionHeart Failure With Mildly Reduced Ejection Fraction
Amgen5,056 enrolled603 locationsNCT07037459
Recruiting
China Cognition and Aging Study
Mild Cognitive Impairment (MCI)Alzheimer Disease, Late OnsetFamilial Alzheimer Disease (FAD)+3 more
Capital Medical University100,000 enrolled65 locationsNCT03653156
Recruiting
The Chinese Familial Alzheimer's Network
Alzheimer DiseaseFamilial Alzheimer Disease (FAD)
Capital Medical University40,000 enrolled65 locationsNCT03657732
Recruiting
BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
Acute Myocardial InfarctionAtrial Fibrillation New Onset
Shanghai 10th People's Hospital774 enrolled5 locationsNCT04528511
Recruiting
Not Applicable
Clinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occlusion Lesions
Coronary Artery Disease (CAD)Chronic Total Occlusions of Coronary Arterieschronic total occlusion (CTO)
The First Affiliated Hospital of Zhengzhou University200 enrolled18 locationsNCT07463664
Recruiting
A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease
Major Cardiovascular EventEstablished Atherosclerotic Cardiovascular Disease
Amgen7,000 enrolled90 locationsNCT06295679
Recruiting
Phase 2Phase 3
A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults
Upper Limb Spasticity
Chongqing Claruvis Pharmaceutical Co., Ltd.254 enrolled24 locationsNCT06783114
Recruiting
Not Applicable
Rectal NSAIDs With/Without PD Stent for PEP Prevention
Post-ERCP Acute PancreatitisNon-steroid Anti-inflammatory DrugsPancreatic Duct Stent Placement
Air Force Military Medical University, China1,278 enrolled15 locationsNCT07117318
Recruiting
CHina Adrenal Venous saMPling InvestigatiON
AdrenalectomyHyperaldosteronismAdrenal Venous Sampling
Chinese Academy of Medical Sciences, Fuwai Hospital5,000 enrolled76 locationsNCT07252284
Recruiting
Phase 3
Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy
Non-Proliferative Diabetic Retinopathy
Beletalent (Zhuhai) Pharmaceutical Co., Ltd360 enrolled30 locationsNCT06817265
Recruiting
Phase 4
REmimazolam vs Propofol Total Intravenous Anesthesia on Outcomes After Major Noncardiac SurgEry
AnesthesiaSurgery--Complications
Nanfang Hospital, Southern Medical University7,188 enrolled44 locationsNCT05728775
Recruiting
Phase 3
Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)
Ischemic Stroke, Acute
Beijing Tiantan Hospital1,380 enrolled82 locationsNCT06157502
Recruiting
Not Applicable
Statins for Treatment of Primary Intracerebral Hemorrhage
Cerebrovascular DisordersIntracranial HemorrhagesIntracerebral haemorrhage+1 more
The Second Hospital of Anhui Medical University264 enrolled22 locationsNCT07088250
Recruiting
Phase 3
A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.642 enrolled25 locationsNCT07003074
Recruiting
Phase 4
Effect of Very Early and Rapid Lowering Cholesterol With Evolocumab on Left Ventricular Remodeling in Patients With Anterior STEMI Undergoing Primary PCI
ST-elevation Myocardial Infarction (STEMI)
Henan Institute of Cardiovascular Epidemiology330 enrolled6 locationsNCT05613426
Recruiting
Phase 3
The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression
MyopiaMyopia Progression
Oupushifang Pharmaceutical Technology Co., Ltd.606 enrolled25 locationsNCT06708156
Recruiting
Phase 4
Fufang Congrong Yizhi Capsules (FCYC) of Cognitive Impairment After Intracerebral Hemorrhage
Cognitive ImpairmentIntracerebral Hemorrhage
Qinhuangdao Hospital of Traditional Chinese Medicine200 enrolled6 locationsNCT06673602
Recruiting
Phase 2
Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation
Relapse/RecurrenceAML, ChildhoodRefractory AML+2 more
Children's Hospital of Soochow University50 enrolled12 locationsNCT06316960
Recruiting
Phase 2
Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML
Acute Myeloid LeukemiaAML, Childhood
Children's Hospital of Soochow University500 enrolled13 locationsNCT06221683